What is the preferred antibiotic, Augmentin (amoxicillin/clavulanate) or Bactrim (trimethoprim/sulfamethoxazole), for treating cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Choice for Cellulitis: Augmentin vs Bactrim

For typical cellulitis without purulent drainage or abscess, neither Augmentin nor Bactrim is the preferred first-line agent—a beta-lactam alone (cephalexin, dicloxacillin, or penicillin) is recommended because streptococci are the primary pathogen and MRSA is uncommon. 1, 2

First-Line Treatment Algorithm

Use a beta-lactam alone as first-line therapy:

  • Cephalexin 500 mg every 6 hours is the preferred oral agent 2
  • Dicloxacillin is equally effective 2
  • Amoxicillin or penicillin are acceptable alternatives 1
  • Treat for 5 days if clinical improvement occurs; extend only if no improvement 1, 2

Between your two options, Augmentin is superior to Bactrim for typical cellulitis because it provides direct coverage against streptococci (the primary pathogen), whereas TMP-SMX has uncertain activity against beta-hemolytic streptococci and should not be used as monotherapy. 1

When to Choose Augmentin Over Simple Beta-Lactams

Consider Augmentin specifically when:

  • Recent amoxicillin use (suggests beta-lactamase producing organisms) 2
  • Traumatic wounds or bite injuries 2
  • Failure to respond to simple beta-lactams 2
  • Mixed infection suspected (provides broader staphylococcal coverage including beta-lactamase producers) 2, 3

Clinical evidence supports Augmentin: A retrospective study of 59 hospitalized patients showed amoxicillin-clavulanate was associated with shorter hospital stays (7.0 ± 2.9 days) and less frequent antibiotic changes compared to cephalosporins or clindamycin. 4

When to Add MRSA Coverage (Making Bactrim Relevant)

Add MRSA-active therapy only when specific risk factors are present:

  • Purulent drainage or exudate visible 1, 2
  • Penetrating trauma, especially injection drug use 1
  • Known MRSA colonization or infection elsewhere 1, 2
  • Failure of beta-lactam therapy after 48 hours 1
  • Systemic inflammatory response syndrome (fever, hypotension, altered mental status) 2

If MRSA coverage is needed, use combination therapy:

  • Clindamycin alone (covers both streptococci and MRSA) 1, 2
  • TMP-SMX PLUS a beta-lactam (cephalexin, amoxicillin, or penicillin) to ensure streptococcal coverage 1, 2
  • Doxycycline or minocycline PLUS a beta-lactam 1

Critical Evidence Against Bactrim Monotherapy

A randomized controlled trial directly tested your question: 146 patients with non-purulent cellulitis received either cephalexin alone or cephalexin plus TMP-SMX. The addition of TMP-SMX provided no benefit—cure rates were 85% vs 82% (risk difference 2.7%, p=0.66). 5 This demonstrates that routine MRSA coverage with TMP-SMX is unnecessary and adds no value for typical cellulitis.

MRSA is an unusual cause of typical cellulitis: A prospective study showed beta-lactams (cefazolin/oxacillin) were successful in 96% of cellulitis cases, confirming MRSA is rarely the culprit. 1

Dosing Considerations If Using TMP-SMX

If you do prescribe TMP-SMX for MRSA coverage, use adequate weight-based dosing:

  • Minimum 5 mg TMP/kg/day (typically TMP-SMX DS 1-2 tablets twice daily for adults >60 kg) 6
  • A retrospective study of 208 hospitalized patients showed inadequate dosing (<5 mg TMP/kg/day) was independently associated with clinical failure (30% vs 17%, OR 2.01, p=0.032) 6

Common Pitfalls to Avoid

Do not routinely cover MRSA in typical cellulitis—this is the most common error. MRSA coverage is unnecessary in 96% of cases without specific risk factors. 1, 2

Do not use TMP-SMX as monotherapy for cellulitis—its activity against streptococci is uncertain, and streptococci are the primary pathogen. Always combine with a beta-lactam if MRSA coverage is needed. 1

Do not automatically treat for 10-14 days—5 days is as effective as 10 days for uncomplicated cellulitis if clinical improvement occurs. 1, 2

Adjunctive Measures

Always address predisposing factors:

  • Elevate the affected extremity to promote drainage 1, 2
  • Examine and treat tinea pedis, toe web maceration, or fissuring 2
  • Manage venous insufficiency, lymphedema, or eczema 1, 2

Summary Decision Tree

  1. Typical cellulitis (no purulent drainage, no risk factors): Use cephalexin or dicloxacillin alone for 5 days 1, 2
  2. If choosing between Augmentin vs Bactrim for typical cellulitis: Choose Augmentin—it covers streptococci directly 2, 4
  3. If MRSA risk factors present: Use clindamycin alone OR TMP-SMX plus cephalexin 1, 2
  4. If failed beta-lactam therapy: Add MRSA coverage with clindamycin or TMP-SMX plus beta-lactam 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.